Literature DB >> 30159607

Correction to: Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer's, but not in frontotemporal dementia.

Mirko Bibl1,2, Marion Gallus3, Volker Welge3, Hermann Esselmann4, Stefanie Wolf5, Eckart Rüther6, Jens Wiltfang4,7.   

Abstract

The respective first and last authors of this article, Mirko Bibl and Jens Wiltfang, would like to clarify the issue of the seeming duplicate publication of a figure in two articles.

Entities:  

Year:  2018        PMID： 30159607      PMCID： PMC6828449          DOI： 10.1007/s00702-018-1914-0

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN： 0300-9564            Impact factor:   3.575


  2 in total

1.  Characterization of cerebrospinal fluid aminoterminally truncated and oxidized amyloid-β peptides.

Authors:  Mirko Bibl; Marion Gallus; Volker Welge; Sabine Lehmann; Katrin Sparbier; Hermann Esselmann; Jens Wiltfang
Journal:  Proteomics Clin Appl       Date:  2012-04       Impact factor: 3.494

2.  Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer's, but not in frontotemporal dementia.

Authors:  Mirko Bibl; Marion Gallus; Volker Welge; Hermann Esselmann; Stefanie Wolf; Eckart Rüther; Jens Wiltfang
Journal:  J Neural Transm (Vienna)       Date:  2012-04-19       Impact factor: 3.575
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.